肠子宫内膜异位症综合征:一种用于盆腔器官功能障碍和生活质量的新评分系统
本研究基于丹麦两家大学医院525例接受药物或手术治疗的肠子宫内膜异位症女性队列,开发并验证了BENS评分。该评分由6个最重要条目组成,总分0-28分,分为无BENS(0-8分)、轻度BENS(9-16分)和重度BENS(17-28分)。外部验证显示BENS评分与生活质量显著相关(P=0.0001)。
要点
- BENS评分基于盆腔痛、镇痛药使用、排便困难、排尿用力、便急和性生活的满意度6个条目。
- BENS评分总分0-28分,0-8分为无BENS,9-16分为轻度BENS,17-28分为重度BENS。
- 外部验证显示BENS评分与生活质量显著相关(P=0.0001)。
核心结论
- BENS评分可用于识别患有肠子宫内膜异位症综合征的女性,并监测药物和手术治疗的效果。
研究设计与样本
- 该评分在丹麦奥胡斯和哥本哈根大学医院525例接受药物或手术治疗的肠子宫内膜异位症女性队列中开发和验证。
- 患者填写盆腔痛、生活质量、泌尿、性功能和肠道功能问卷。
- 采用临床和统计学标准选择条目,所选变量纳入多变量分析,并进行了内部和外部验证。
主要发现
- 6个最重要的条目为盆腔痛、镇痛药使用、排便困难、排尿用力、便急和性生活的满意度。
- BENS评分范围为0-28分,分为0-8分(无BENS)、9-16分(轻度BENS)和17-28分(重度BENS)。
- 外部验证显示BENS评分与生活质量显著相关(P=0.0001)。
关键数值与推荐
- BENS评分总分0-28分,0-8分为无BENS,9-16分为轻度BENS,17-28分为重度BENS。
临床怎么用
- 原文未据此给出推荐。
局限性
- BENS评分系统受限于它是在丹麦一个单一的子宫内膜异位症中心开发的,容易受到社会、文化和人口学偏倚的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Is it possible to develop a validated score that can identify women with Bowel Endometriosis Syndrome (BENS) and be used to monitor the effect of medical and surgical treatment? SUMMARY ANSWER: The BENS score can be used to identify women with BENS and to monitor the effect of medical and surgical treatment of women suffering from bowel endometriosis. WHAT IS KNOWN ALREADY: Endometriosis is a heterogeneous disease with extensive variation in anatomical and clinical presentation, and symptoms do not always correspond to the disease burden. Current endometriosis scoring systems are mainly based on anatomical and surgical findings. STUDY DESIGN, SIZE, DURATION: The score was developed and validated from a cohort of 525 women with medically or surgically treated bowel endometriosis from Aarhus and Copenhagen University Hospitals, Denmark. PARTICIPANTS/MATERIALS, SETTING AND METHODS: Patients filled in questionnaires on pelvic pain, quality of life (QoL) and urinary, sexual and bowel function. Items were selected for the final score using clinical and statistical criteria. The chosen variables were included in a multivariate analysis. Individual score values were designated items to form the BENS score, which was divided into 'no BENS', 'minor BENS' and 'major BENS.' Internal and external validations were performed. MAIN RESULTS AND THE ROLE OF CHANCE: The six most important items were 'pelvic pain', 'use of analgesics', 'dyschezia', 'straining to urinate', 'fecal urgency' and 'satisfaction with sexual life'. The range of the BENS score (0-28) was divided into 0-8 (no BENS), 9-16 (minor BENS) and 17-28 (major BENS). External validation showed a significant association between BENS score and QoL (P = 0.0001). LIMITATIONS, REASONS FOR CAUTION: The BENS scoring system is limited by the fact that it was developed from a single endometriosis unit in Denmark, making it susceptible to social, cultural and demographic bias. WIDER IMPLICATIONS OF THE FINDINGS: It is the first endometriosis classification system to be based directly on the symptomatology of the patient. Validation in other languages will promote comparison of treatments and results across borders. STUDY FUNDING/COMPETING INTEREST(S): No external funding was either sought or obtained for this study. A.F. is an investigator for Bayer, outside this work.
引用
- Riiskjær M, Egekvist AG, Hartwell D, et al. Bowel Endometriosis Syndrome: a new scoring system for pelvic organ dysfunction and quality of life. Hum Reprod. 2017. PMID: 28854723. doi:10.1093/humrep/dex248
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。